Member Info for urbansea89

Think I said a few weeks ago that I’d been out for a long time and I’d been persuaded by a friend that this was real. I was a glad to have been persuaded at that time and have been hugely reassured again since then.

It’s a great privilege to ride on the back of all of your knowledge and insight, mostly on the same trajectory. I’m sure we will soon have our day and, more importantly, as will the patients who need this more than we do.

It’s on the way now for sure. Now about sitting back and appreciating the actions of a superb management team and an incredible science team to fine tune this wonder of a company to its best effect.

Big thanks to a great posting board for keeping the faith and providing (on the whole) such great insight. 👏

I’m so looking forward to the next few weeks.

Extraordinary week for Avacta. Christina and team have knocked it out of the park. Huge congrats to you all. Amazing times ahead.

I think you are so wrong. I thankfully was persuaded by someone I met with recently to come back in. I was sceptical but slept on it and read through where things were. Thankfully I bought back in.

Today’s presentation was the most compelling I’ve seen from Avacta in years. I thought the FD was good by the way, I like the abrupt style, confident and straightforward.

Christina C filled me with belief. I liked the way she handled confidentiality without leaving us guessing.

Impressive all round and potentially extraordinary what’s about to happen.

Huge congrats all round.

I’d be grateful if someone would let me have the link and start time for Tuesday’s update.

I’ve not logged in for some time but getting the feeling it’s beginning to look quite interesting.

An impressive RNS at long last, confident, to the point and very ‘front foot’. 👋

what a ******. totally disdain.

just looked first time today since a **** morn, blimey, what the heck. so so exciting and deserved, more for you all as i’m more passive but so so happy to be involved.

congrats to you all for the now inevitable. just on the cusp.

WE could end up being the big Pharma Yeboha. Let’s start taking the revenue and keep it growing rapidly on the back of game changing science. So much more to develop having now unlocked the path for the future.

Never in doubt! Outstanding news today. Congrats to everyone involved.

Looks like it’s on all the way and options galore on the ways forward.

I can now appreciate that it was far better for the full progress story to be uncovered through the science day, as it has been done. It would have been tricky to release such complex data in an RNS which could have been open to overreaction and chains of interpretation.
The debrief has been thorough, unambiguous and extremely well presented. It’s been handled with delicacy and due care.
I’m also even more mindful of those patients who have taken part with little prospect of the trial affecting their outcome and through their actions, have cleared a path for those in the next stage, who do have a far greater chance of benefitting.
Whilst the trial team have no doubt been excited by the science and the results to date, it must have been a sombre rapport with patients they’ve interacted with during the trial.
The progress presented looks as good as anyone could have hoped for and presents real prospect now of going all the way. Quite incredible.

I'm a bit confused why yesterday's RNS said ''No material new information will be disclosed as part of this meeting''.
The data on P84 and P85 seems pretty material to me and goes much further than ''meaningful'' amounts found in tumor biopsies.

It’s a ballsy mission statement. Whatever may come out of tomorrow, or soon after, there’s going to be quite an epiphany when more detail is disclosed.
GLA all, big times ahead.

The last update and the video were superb. There was nothing vague and all that we need to consider our investment. This is massive and once it progresses through the next stage will redefine what the meaning of ‘disruptive’ is. In my opinion it may not be acquirible.

Solid gains and hugely exciting to see such a steady move. It is a pittance though considering the clinical breakthrough that’s in the public domain. One can only imagine where we end up once this is in mainstream media and the true realisation of the achievement. I guess it’s going to be a complex one to handle for the big industry community- how a tiny Company has brought this game changer close to reality and who is going to stump up a fortune to buy in or even attempt to acquire.
Congrats to all.

Def stick. Never get a chance like it again, to be part of something so special. Loads of valuation scenarios should be thrown out of the window if this continues to progress in the way it’s going. It’s not pie in the sky, need to remind ourselves this is happening and there are likely to be more funding/expansive plays under the bonnet than are apparent at the moment.

Not a cat in hells. The problem with Avacta is no one can afford to buy it. The disruption is a problem and the cost to acquire is an even bigger problem. It’s worth a fortune and should be seen as that and held long term.

In my opinion, by far the best interview delivered by him. No Re-assurance required or grey areas or any doubts. Really like the US sites being brought into the picture aswell.
Down to fine tuning now.

Was a wonderful week and the best possible, long awaited news was well delivered. Congrats all and have a great weekend.

It makes complete sense to focus further on dose levels. Greater clarity on this will provide so much for the next phase and increase the scale of the treatment opportunity. All came across so well in the Vox audio. Great job.